Advertisement
AXON vs SEER
Which Stock Would AI Choose? Axon Enterprise (AXON) vs. Seer (SEER) Stock Comparison
Key Takeaways
- Axon Enterprise (AXON) operates in the public safety technology sector with consistent revenue growth exceeding 30% in recent quarters, while Seer (SEER) focuses on proteomics tools in the biotechnology space with limited commercial traction.
- Recent market activity shows AXON trading near $528 with solid year-to-date performance, whereas SEER trades around $2.22 amid higher volatility typical of early-stage life sciences firms.
- AXON benefits from recurring software and services revenue streams, contrasting with SEER's reliance on product suite adoption in research laboratories.
- Sector exposure differs markedly: AXON aligns with law enforcement and enterprise safety solutions, while SEER targets academic and biopharmaceutical research applications.
- Relative performance reflects AXON's established market position versus SEER's higher-risk profile tied to technology commercialization milestones.
- Market sentiment favors AXON for stability and growth catalysts, with SEER exhibiting sensitivity to broader biotech funding and adoption trends.
Introduction
This comparison examines AXON and SEER to highlight contrasts in business models, recent performance, and market positioning. Investors and traders seeking exposure to technology-driven growth sectors—such as public safety solutions or life sciences instrumentation—may find the analysis relevant for portfolio diversification or sector rotation decisions. The review draws on observable financial metrics and developments to provide a balanced view of relative strengths without forward-looking projections.
Axon Enterprise (AXON) Overview and Recent Performance
Axon Enterprise develops technology solutions for law enforcement and public safety, including conducted energy devices, body-worn cameras, and cloud-based software platforms. The company has reported sustained revenue expansion, with software and services contributing significantly to results in recent periods. Recent market activity reflects steady demand for its ecosystem, supported by adoption of AI-enhanced features and platform integrations. Performance in the past several weeks has been influenced by broader interest in public safety technology and analyst commentary on operational execution. Sentiment remains supported by recurring revenue visibility and expansion into adjacent markets such as counter-drone systems.
Seer (SEER) Overview and Recent Performance
Seer develops and commercializes proteomic analysis tools, including its Proteograph Product Suite that enables detailed protein profiling for research use. The biotechnology company targets academic institutions, life sciences laboratories, and biopharmaceutical firms. Recent market activity has featured price fluctuations consistent with small-cap healthcare equities, with movements tied to product adoption updates and sector-wide sentiment. Performance over recent weeks shows variability influenced by quarterly financial disclosures and broader market conditions affecting early-stage life sciences companies. Sentiment reflects ongoing efforts to expand commercial reach amid typical challenges in scaling novel instrumentation technologies.
Trending AI Robots
Tickeron maintains a curated Trending AI Robots page that features select AI trading bots optimized for prevailing market conditions. While the platform offers hundreds of AI trading bots capable of trading thousands of different tickers, only those demonstrating strong suitability based on current trends, strategies, and statistical profiles are highlighted in this section. Available bots span a wide range of trading styles, timeframes, performance metrics, and ticker universes, with historical win rates and return profiles varying by strategy—some achieving double-digit compounded returns over multi-month periods in backtested or live environments. This diversity allows users to evaluate options aligned with specific risk tolerances and market views. Explore the full selection on the Trending AI Robots page for detailed statistics and configuration details.
Head-to-Head Comparison
Axon Enterprise (AXON) and Seer (SEER) operate in distinct sectors with differing growth profiles. AXON emphasizes an integrated hardware-software model serving government and enterprise clients, generating stable recurring revenue, while SEER provides specialized research tools with revenue dependent on instrument placements and consumable sales. Recent momentum favors AXON due to demonstrated revenue scalability, contrasting with SEER's focus on technology validation and market penetration in proteomics. Risk factors include regulatory and contract dependencies for AXON versus clinical adoption and funding cycles for SEER. Sector exposure places AXON in industrials and technology applications, while SEER remains within healthcare and biotechnology. Market sentiment reflects greater visibility around AXON's operational metrics compared to the higher uncertainty typical of pre-profit life sciences firms.
Tickeron AI Verdict
Based on observable factors such as trend consistency, revenue stability, and relative market positioning, Tickeron’s AI would currently assign a higher probabilistic preference to AXON over SEER. The established growth trajectory and diversified revenue base provide a more consistent profile amid broader market conditions, whereas SEER exhibits characteristics associated with elevated volatility in the biotechnology segment.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Buy and SEER is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AXON’s FA Score shows that 1 FA rating(s) are green whileSEER’s FA Score has 1 green FA rating(s).
- AXON’s FA Score: 1 green, 4 red.
- SEER’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AXON’s TA Score shows that 4 TA indicator(s) are bullish while SEER’s TA Score has 3 bullish TA indicator(s).
- AXON’s TA Score: 4 bullish, 4 bearish.
- SEER’s TA Score: 3 bullish, 5 bearish.
Price Growth
AXON (@Aerospace & Defense) experienced а +7.32% price change this week, while SEER (@Biotechnology) price change was -4.15% for the same time period.
The average weekly price growth across all stocks in the @Aerospace & Defense industry was +3.40%. For the same industry, the average monthly price growth was +9.64%, and the average quarterly price growth was +8.33%.
The average weekly price growth across all stocks in the @Biotechnology industry was +0.51%. For the same industry, the average monthly price growth was -1.43%, and the average quarterly price growth was +2992.28%.
Reported Earning Dates
AXON is expected to report earnings on Nov 10, 2026.
SEER is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Aerospace & Defense (+3.40% weekly)Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.
@Biotechnology (+0.51% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| AXON | SEER | AXON / SEER | |
| Capitalization | 49.8B | 115M | 43,304% |
| EBITDA | 320M | -68.48M | -467% |
| Gain YTD | 7.906 | 13.661 | 58% |
| P/E Ratio | 255.35 | N/A | - |
| Revenue | 2.98B | 14.7M | 20,293% |
| Total Cash | 737M | 167M | 441% |
| Total Debt | 1.83B | 23M | 7,948% |
AXON | ||
|---|---|---|
OUTLOOK RATING 1..100 | 41 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 56 | |
SMR RATING 1..100 | 81 | |
PRICE GROWTH RATING 1..100 | 39 | |
P/E GROWTH RATING 1..100 | 21 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AXON | SEER | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 62% | 3 days ago 78% |
| Stochastic ODDS (%) | 3 days ago 78% | 3 days ago 87% |
| Momentum ODDS (%) | 3 days ago 85% | 3 days ago 81% |
| MACD ODDS (%) | 3 days ago 70% | 3 days ago 78% |
| TrendWeek ODDS (%) | 3 days ago 76% | 3 days ago 83% |
| TrendMonth ODDS (%) | 3 days ago 73% | 3 days ago 83% |
| Advances ODDS (%) | 6 days ago 74% | 14 days ago 74% |
| Declines ODDS (%) | 18 days ago 70% | 3 days ago 83% |
| BollingerBands ODDS (%) | 3 days ago 66% | 3 days ago 87% |
| Aroon ODDS (%) | N/A | N/A |
Advertisement
AXON and
Correlation & Price change
A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.
| Ticker / NAME | Correlation To AXON | 1D Price Change % | ||
|---|---|---|---|---|
| AXON | 100% | -0.45% | ||
| TECH - AXON | 61% Loosely correlated | +0.32% | ||
| VCYT - AXON | 58% Loosely correlated | -3.17% | ||
| BEAM - AXON | 57% Loosely correlated | +0.91% | ||
| SEER - AXON | 56% Loosely correlated | -0.95% | ||
| ADPT - AXON | 56% Loosely correlated | +1.14% | ||
More | ||||
SEER and
Correlation & Price change
A.I.dvisor indicates that over the last year, SEER has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SEER jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To SEER | 1D Price Change % | ||
|---|---|---|---|---|
| SEER | 100% | -0.95% | ||
| AXON - SEER | 56% Loosely correlated | -0.45% | ||
| ARRY - SEER | 47% Loosely correlated | -2.32% | ||
| DNA - SEER | 37% Loosely correlated | -6.22% | ||
| VCYT - SEER | 35% Loosely correlated | -3.17% | ||
| RNA - SEER | 33% Loosely correlated | +4.14% | ||
More | ||||